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Abstract
Background—Though hypertension is a commonly studied risk factor for white matter lesions 
(WMLs), measures of blood pressure may fluctuate depending on external conditions resulting in 
measurement error. Indicators of arterial stiffening and reduced elasticity may be more sensitive 
indicators of risk for WMLs in aging; however the interdependent nature of vascular indicators 
creates statistical complications.
Objective—The purpose of the study was to determine whether a factor score comprised of 
multiple vascular indicators would be a stronger predictor of WMLs than traditional measures of 
blood pressure.
Methods—In a sample of well-characterized nondemented older adults, we used a factor analytic 
approach to account for variance common across multiple vascular measures while reducing 
measurement error. The result was a single factor score reflecting arterial stiffness and reduced 
elasticity. We used this factor score to predict white matter lesion volumes acquired via fluid 
attenuated inversion recovery (FLAIR) magnetic resonance imaging.
Results—The combined vascular factor score was a stronger predictor of deep WML (β = 0.42, p 
< 0.001) and periventricular WML volumes (β = 0.49, p < 0.001). After accounting for the 
vascular factor, systolic and diastolic blood pressure measurements were not significant predictors.
Conclusions—This suggests that a combined measure of arterial elasticity and stiffening may 
be a stronger predictor of WMLs than systolic and diastolic blood pressure accounting for the 
multicollinearity associated with a variety of interrelated vascular measures.
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Typical aging is associated with an accumulation of deleterious effects on brain structure, 
including degeneration in white matter [1]. White matter is particularly susceptible to age-
associated changes, especially cerebrovascular disorders and ischemia [2–4]. White matter 
lesions (WMLs), detectable through magnetic resonance imaging (MRI), increase with age 
and are common in older adults including those who are otherwise healthy [5]. 
Accumulation of WMLs is associated with poor cognitive function [6, 7], risk of dementia 
and stroke [8, 9], and depressive symptoms [10]. Two major classifications of WMLs are 
periventricular (PVWMLs), those contiguous with the margins of the lateral ventricles, and 
subcortical or “deep” (DWMLs), those that are separate from the ventricles. PVWMLs have 
generally been associated with cognitive changes, whereas those fully bounded by white 
matter (“deep”) have more often been associated with depression and related illnesses [1, 11, 
12].
Vascular risk factors are precursors of both types of WMLs. Hypertension is associated with 
increased rates of both PVWMLs and DWMLs [13] and duration of hypertension is an 
important factor [13, 14]. Some studies suggest that control of hypertension with 
medications results in less severe WMLs [13]. However, both increases and decreases in 
blood pressure are associated with more severe PVWMLs [15]. Though hypertension is a 
commonly studied vascular risk factor for WMLs, investigation of other vascular indicators 
such as arterial stiffening may shed light on the causes and consequences of WMLs in aging 
[16]. Arterial stiffening, thickening, and endothelial dysfunction have been associated with 
severity of WMLs and cognitive decline independent of blood pressure level [17]. Duprez et 
al. [18] reported that reduced large and small artery elasticity were associated with greater 
severity of cerebral WMLs and not significantly associated with blood pressure levels. The 
ability of the small and large arteries to stretch with increased blood flow (i.e., sheer stress) 
is an indicator of elasticity. Small and large artery elasticity indices are markers of 
arteriosclerosis and atherosclerosis respectively and linked to WMLs [19]. Decreased 
elasticity due to aging is associated with a reduction in blood flow toward the brain [20].
Several vascular indicators may predict WMLs even after accounting for blood pressure. 
However, due to the interdependent nature of these vascular measures, they are highly 
overlapping in their contributions to statistical variation, thus creating problems with 
multicollinearity. A factor analytic approach to this analysis allows us to account for the 
variance in common between the separate items and eliminate variance due to measurement 
error or variance due to unique characteristics of each measure [21]. Thus, a factor analytic 
model will allow us to better investigate a combination of multiple vascular risk factors 
reflecting arterial stiffness and reduced elasticity. We hypothesize that this combined 
vascular risk factor will be associated with WMLs even after accounting for traditional 
measures of blood pressure and other potential covariates.
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Data were collected from participants enrolled in the Brain Aging Project at the University 
of Kansas. The Brain Aging Project was designed as a longitudinal observational study of 
older adults, both nondemented individuals and those with early-stage AD, 65 years and 
older. The Brain Aging Project focused on the assessment of physical health and 
metabolism. The present study included nondemented participants who had a battery of tests 
including a clinical assessment, metabolic assessment, vascular compliance, cardiovascular 
fitness assessment, and structural MRI, among other tests documented in previous 
publications [22–25]. All study procedures were conducted in accordance with the Helsinki 
Declaration of 1975 and approved in compliance of the ethical standards of the University of 
Kansas Medical Center Institutional Review Board. Participants were recruited by self-
referral in response to media coverage and word of mouth. Informed consent was obtained 
for all participants prior to enrollment into the study.
The present study reports findings for healthy older adult control participants (n = 63) who 
were without evidence of functional cognitive impairment (Clinical Dementia Rating [CDR] 
0) [26]. We excluded participants who were missing data for the vascular measures or whose 
MRI scan was excluded due to movement or artifact based on visual inspection. Study 
exclusions at baseline include diabetes mellitus (clinical diagnosis, use of an anti-diabetic 
agent, or 2-h post-load serum glucose >199), unstable ischemic heart disease within the last 
2 years as previously described, neurological disease, schizophrenia, clinically significant 
depression, abnormalities in serum vitamin B12 levels, thyroid disease, use of psychoactive 
or investigational medications, significant visual or auditory impairment, history of alcohol 
abuse, and systemic illness that would impair completion of the study [22]. Participants were 
excluded if they had mobility impairments that would interfere with exercise testing. 
Twenty-nine percent of our participants reported using blood pressure medications including 
ACE inhibitors, angiotensin 2 receptor blocker, beta blockers, calcium channel blockers, 
diuretics, and thiazides.
Vascular measures
A nurse clinician recorded the participants’ vital signs, including cardiovascular dynamics 
(blood pressure, heart rate, estimated cardiac output, arterial elasticity, vascular resistance, 
body temperature, and estimated stroke volume) which were measured after approximately 
20 min supine using the PulseWave CR-2000 (Hypertension Diagnostics, Eagan, MN). A 
standard sphygmomanometer cuff was placed over the dominant upper arm and an 
automated tonometer was placed over the radial artery. Blood pressure was assessed using 
the average of two measurements. Pulse pressure was calculated as systolic blood pressure 
minus diastolic blood pressure. Measures of vascular compliance were determined (non-
invasively) by recording the radial artery pulse contour by tonometry. The measure was 
obtained by a technician experienced with the technique using the equipment to assess both 
large (C1) and small (C2) artery elasticity.
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The vascular compliance test uses two compliance elements, C1 and C2, and inertance and 
resistance elements to estimate the elasticity of the radial artery. With the use of a computer 
algorithm the morphology of the arterial pulse contour can be separated into an exponential 
diastolic decay generated by the release of blood from the large arteries and a sinusoidal 
wave arising from peripheral wave reflections. The diastolic decay is a function of large 
artery compliance (C1), while reflections or oscillations represent the compliance 
characteristics of the resistance vessels and branch points (C2). A comparison of direct 
brachial artery cannulation with combined radial artery tonometry and oscillometric 
measurement of brachial artery blood pressure shows a close correlation of systolic, 
diastolic, and mean arterial blood pressure, cardiac output, with C2 in subjects with well-
maintained cardiac output. Arterial elasticity is the measurement of the ability of the artery 
to stretch in response to each pulse, arterial compliance is the change in volume divided by 
the change in pressure, and the systemic vascular resistance is calculated from mean arterial 
blood pressure and estimated cardiac output [27].
Neuroimaging
Structural MRI data were obtained using a Siemens 3.0 Tesla Allegra MRI Scanner. Fluid 
attenuated inversion recovery (FLAIR) images were used for white matter lesion 
assessments (Ti = 2500, TR = 10,000, TE = 81.0, flip angle = 180°, slice thickness = 4 mm 
with 0 gap). WMLs (PVWMLs (contiguous with the ventricle) and DWMLs) were manually 
traced on FLAIR images as a measure of vascular related brain injury using Medical Image 
Processing, Analysis, and Visualization (MIPAV, Johns Hopkins University) expressed as 
volume in mm3. A single rater (LH) was trained to a threshold of <10% error and reliability 
of white matter assessments were assessed with 10 blinded repeat assessments inserted 
randomly into the rater’s workflow. The training set used to learn this method was randomly 
sampled drawn from a larger pool of 191 images, given a random identifier at each rating 
during training, and provided in batches of 20 (including 10 previously rated images) until 
repeat absolute error was below 10%. Intra-rater reliability was excellent, absolute-
agreement ICC(3,2) = 0.88 (F = 9.9, df = 51, p < 0.001).
Statistical analysis
As several of the vascular variables were non-normally distributed, we followed standard 
practice for correction of skewed distributions that violate assumptions of normality by 
using logarithmic transformation for small and large artery elasticity, and systemic vascular 
resistance. To convert all variables into a comparable metric we used percent of maximum 
scoring (observed score − minimum score/maximum score − minimum score)× 100). This 
approach is less problematic than using Z-scores [28]. For those variables requiring log 
transformation, percent of maximum scoring was conducted on the log transformed scores.
We conducted confirmatory factor analysis (CFA) using Mplus version 5 [29] to evaluate 
the inter-correlations among independent vascular measures including stroke volume, large 
and small artery elasticity, and vascular resistance. This approach offers improved 
measurement accuracy by aggregating common variance across multiple subtests and 
attenuating error idiosyncratic to the individual measures. In accordance with guidelines for 
proper execution of CFA techniques, we applied theoretical reasoning and well-established 
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clinical observation to the practice of selecting variables to include, testing models, and 
interpreting the results [30].
Goodness-of-fit was evaluated based on root mean square error of approximation (RMSEA), 
which is a measure of discrepancy between predicted and observed model values; values 
closer to 0 indicate better fit (preferred values <0.09). We also report the comparative fit 
index which estimates the relative fit of a model compared to an alternative model (CFI 
>0.90 indicates good fit). We used full information maximum likelihood algorithm to 
account for missing data.
We hypothesized that a single common factor would best describe the relationship among 
the vascular measures. Factor analysis was used to evaluate what individual tests had in 
common, rather than what they did not share. The factor weights estimated from the factor 
analysis were converted to factor scores that were used in subsequent analyses. Rather than 
assuming that each vascular measure contributes equally, factor analysis was used to 
estimate the relative importance and measurement error associated with each individual 
measure. These estimates (factor weights) were used to create a weighted factor score 
combining individual measures together into a single score. Thus, the vascular factor score 
contains the scores for each individual measure weighted by its relative contribution to the 
whole and adjusted for the measurement error associated with each measure.
To estimate the effect of the combined vascular factor, after accounting for the effects of 
systolic and diastolic blood pressure, on WMLs we used stepwise multiple regression 
models in which the vascular factor predicted neuroimaging measures accounting for age, 
gender, education, body mass index (BMI), use of anti-hypertensive medication, and 
apolipoprotein (APOE) ε4 carrier status. We include education as a covariate because there 
is evidence that education is important in estimating the impact of WMLs on cognitive 
function [31]. These analyses were conducted both including and excluding individuals with 
no evidence of WMLs to ensure that the results were not driven by those cases. The effect of 
the vascular factor on presence or absence of WMLs may be separate from the extent of 
WML damage in those with evidence of WMLs.
RESULTS
Table 1 summarizes the participant characteristics. For calculation of the vascular factor 
scores, the hypothesized one factor model fit the data (X2(df) = 2.8(2); CFI = 0.97; RMSEA 
= 0.06). All the measures loaded significantly on the factor (Table 2). Vascular factor scores 
used in subsequent regression analysis were based on the weights (standardized loadings) 
and error terms specified in this analysis (see Table 2 for the loadings and error terms 
combined to create the factor scores). Higher vascular scores were positively correlated with 
older age (R = 0.43, p < 0.001).
Deep white matter lesions
Stepwise regression indicated that higher scores on the combined vascular factor (β = 0.42, p 
= 0.001) and years of education (β = 0.26, p = 0.03) significantly predicted greater deep 
WML volume adjusting for age, gender, systolic and diastolic blood pressure, BMI, 
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antihypertensive medication use, and APOE ε4 carrier status (adjusted R2 = 0.18). In 
analyses including only patients with evidence of DWMLs (n = 44), the combined vascular 
factor (β = 0.48, p = 0.001) and years of education (β = 0.28, p = 0.049) significantly 
predicted greater deep WML volume adjusting for age, gender, systolic and diastolic blood 
pressure, BMI, antihypertensive medication use, and APOE ε4 carrier status (adjusted R2 = 
0.23).
Periventricular white matter lesions
Age (β = 0.43, p < 0.001), gender (β = −0.31, p = 0.007), and education (β = 0.23, p = 0.04) 
significantly predicted periventricular WMLs adjusting for the same covariates (adjusted R2 
= 0.26). The vascular factor did not predict PVWMLs when all participants were included. 
However, in analyses including only patients with evidence of PVWMLs (n = 58), higher 
scores on the combined vascular factor (β = 0.50, p < 0.001) and years of education (= 0.29, 
p < 0.014) predicted greater lesion volume adjusting for age, gender, systolic and diastolic 
blood pressure, BMI, antihypertensive medication use, and APOE ε4 carrier status (adjusted 
R2 = 0.27).
DISCUSSION
Our data suggest that combining related vascular measures into a single factor score allows 
us to better examine the relationships between arterial stiffness, reduced elasticity, and 
WMLs, instead of relying on blood pressure measures that fluctuate depending on external 
conditions and create measurement error. Our vascular factor was a stronger predictor than 
blood pressure in regression analyses. In fact, systolic and diastolic blood pressure did not 
contribute significant variance to explaining WMLs when the vascular factor was included 
the model. Using CFA improves measurement accuracy by combining common variance 
across vascular measures and minimizing error that is unique to the individual measures. 
Using a more robust measure of vascular health may be more informative than using a 
measure such as blood pressure when investigating brain health during aging. While some 
studies have reported associations between blood pressure and WMLs [33], several others 
report no association or associations that are inconsistent. For example, the relationship 
depended on age of individuals measured or time of day when measured [33–35]. These 
inconsistencies may be due to the variability in blood pressure measures, or the likelihood of 
individuals on medications for hypertension having lowered blood pressure values, which 
might otherwise have been associated with WML. In our study, use of anti-hypertensive 
medications did not predict WMLs after accounting for the other predictors and covariates in 
the models.
Since white matter is particularly susceptible to age-associated changes [2–4], using a stable 
measure of vascular health with reduced measurement error allows us greater confidence in 
understanding the role of vascular disease on the brain. In our study we used vascular 
measures such as arterial stiffness, arterial elasticity, and estimated stroke volume that are 
better reflections of overall vascular health than simple blood pressure, which is more 
subject to fluctuations due to correct size of blood pressure cuff, time of day, body and arm 
position, and medication use. White coat hypertension, persistently elevated blood pressure 
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in the presence of health care providers in individuals not taking medication, also makes 
accurate detection of hypertension difficult [36], and studies suggest that management of 
white coat hypertension should include cardiovascular risk factors, not blood pressure alone 
[37].
Both deep and periventricular WMLs were associated with the vascular factor in 
nondemented elderly. Lower elasticity and higher vascular resistance were associated with 
greater white matter lesion volumes. The two classes of WMLs have been associated with 
different etiologies and outcomes. For example, some evidence suggests that PVWMLs may 
predict the rate of cognitive decline [38] and poorer executive function in nondemented 
patients [39], and are associated with hypometabolism in frontal regions [39]. PVWMLs are 
preferentially associated with atherosclerosis, changes in hemodynamics, and hypoperfusion 
[5]. DWMLs, by contrast, have more often been related to depression and related illnesses 
[1, 11, 12] and are more likely attributed to hypertension and homocysteine levels, both risk 
factors for small vessel disease [5]. Individuals with cardiovascular disease typically have a 
compromised peripheral vascular system including hypertension and poor arterial 
compliance [27]. Using a computerized device that generates information about 
cardiovascular health such as the one used in this study and using the combined vascular 
factor could be beneficial for determining the incidence of and risk for small vessel disease. 
The unique information provided by the vascular factor score may provide clinicians with 
useful information for those at risk for small vessel disease. Previous studies suggest that 
small vessel disease burden is an independent predictor of measures of memory, language, 
and executive function [40]. Using indicators of arterial stiffness instead of blood pressure 
could be used to more accurately evaluate these individuals and deliver a lifestyle or 
pharmaceutical intervention before cerebrovascular damage such as WML occurs.
Limitations of the study include limited generalizability due to our highly educated, mostly 
Caucasian, Midwestern American sample. Many clinical studies of older adults suffer from 
a difficulty in recruiting diverse samples and our center is engaged in ongoing efforts to 
expand the sample to be more diverse and representative. Our findings are consistent with a 
previous study of small artery elasticity in a multi-ethnic cohort demonstrating that small 
artery elasticity is a risk factor for cerebrovascular events beyond the effects of blood 
pressure [18]. A further limitation of the study was that we were unable to estimate 
reliability for the pulse wave, tonometry, and white matter lesion measures, as each was 
performed by a single trained rater.
Aging and chronic hypertension facilitate arterial stiffening across the lifespan and 
ultimately affect cerebrovascular health including WMLs [41]. Our research suggests that a 
vascular factor including measures of arterial stiffening and reduced elasticity may be more 
sensitive for predicting WMLs than traditional measures of blood pressure after accounting 
for the multicollinearity associated with the variety of interrelated vascular measures.
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Table 1
Participant characteristics (n = 63)
n (%)
Gender (Female) 36 (57%)
Race (Caucasian) 63 (100%)
APOE ε4 Carrier 18 (29%)
Use of Antihypertensive Medications 18 (29%)
M (SD)
Age (years) 73.3 (6.8)
Education (years) 16.4 (2.6)
Systolic Blood Pressure (mm/Hg) 130.0 (15.7)
Diastolic Blood Pressure (mm/Hg) 72.2 (9.9)
Body Mass Index (kg/m2) 26.30 (3.7)
Stroke Volume (mL/beat) 68.2 (13.4)
Large Artery Elasticity (mL/mmHg ×10) 13.7 (5.4)
Small Artery Elasticity (mL/mmHg ×100) 4.3 (2.5)
Systemic Vascular Resistance (dynes cm5) 1641.6 (332.6)
Deep WML Volume (cm3) 308.37 (649.25)
Periventricular WML Volume (cm3) 881.67 (1262.60)
Total white matter lesion volume (cm3) 1190.04 (1850.98)
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Table 2
Factor loadings for vascular measures
Std Loading (λ) Std Residual (Error) Variances
Stroke Volume 0.75* 0.44*
Large Artery Elasticity 0.71* 0.49*
Small Artery Elasticity 0.79* 0.38*
Vascular Resistance 0.94* 0.13
*
p < 0.001. Note: Standardized loadings (λ) reflect the strength of the relationship of each item with the shared vascular factor. Similar to a 
correlation coefficient (range 0.00 to 1.00), a higher number indicates a stronger association.
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